HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development

February 23, 2023

VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announced that it has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License granted by Health Canada in accordance with the Controlled Drugs and Substances Act. This announcement is a significant development supporting HYTN’s mission to be a leading manufacturer of psychoactive and psychotropic compounds.

Read more at globenewswire.com

Related news for (HYTNF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.